146 related articles for article (PubMed ID: 11027359)
1. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin.
Ruschitzka FT; Wenger RH; Stallmach T; Quaschning T; de Wit C; Wagner K; Labugger R; Kelm M; Noll G; Rülicke T; Shaw S; Lindberg RL; Rodenwaldt B; Lutz H; Bauer C; Lüscher TF; Gassmann M
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11609-13. PubMed ID: 11027359
[TBL] [Abstract][Full Text] [Related]
2. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary arterial pressure and electrocardiograms in broiler chickens infused intravenously with L-NAME, an inhibitor of nitric oxide synthase, or sodium nitroprusside (SNP), a nitric oxide donor.
Weidong S; Xiaolong W; Jinyong W; Ruiping X
Br Poult Sci; 2002 May; 43(2):306-12. PubMed ID: 12047097
[TBL] [Abstract][Full Text] [Related]
5. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ
BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia.
Clarke ZL; Moat SJ; Miller AL; Randall MD; Lewis MJ; Lang D
Eur J Pharmacol; 2006 Dec; 551(1-3):92-7. PubMed ID: 17045583
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin-induced excessive erythrocytosis activates the tissue endothelin system in mice.
Quaschning T; Ruschitzka F; Stallmach T; Shaw S; Morawietz H; Goettsch W; Hermann M; Slowinski T; Theuring F; Hocher B; Lüscher TF; Gassmann M
FASEB J; 2003 Feb; 17(2):259-61. PubMed ID: 12490547
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin system.
Kalk P; Mach A; Thone-Reineke C; Godes M; Heiden S; Sharkovska Y; von Websky K; Relle K; Hocher B
Can J Physiol Pharmacol; 2008 Aug; 86(8):541-5. PubMed ID: 18758502
[TBL] [Abstract][Full Text] [Related]
9. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
[TBL] [Abstract][Full Text] [Related]
10. Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
Harrison CB; Drummond GR; Sobey CG; Selemidis S
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):429-34. PubMed ID: 19843095
[TBL] [Abstract][Full Text] [Related]
11. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries.
Lekontseva O; Chakrabarti S; Jiang Y; Cheung CC; Davidge ST
J Pharmacol Exp Ther; 2011 Nov; 339(2):367-75. PubMed ID: 21807885
[TBL] [Abstract][Full Text] [Related]
12. Mediation by nitric oxide of the carbachol-induced corticosterone secretion in rats.
Bugajski J; Borycz J; Gadek-Michalska A; Głód R; Bugajski AJ
J Physiol Pharmacol; 1997 Jun; 48(2):277-84. PubMed ID: 9223031
[TBL] [Abstract][Full Text] [Related]
13. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature.
Emerson M; Momi S; Paul W; Alberti PF; Page C; Gresele P
Thromb Haemost; 1999 Jun; 81(6):961-6. PubMed ID: 10404776
[TBL] [Abstract][Full Text] [Related]
14. Effect of nitric oxide synthase inhibitor on optic nerve head circulation in conscious rabbits.
Sugiyama T; Oku H; Ikari S; Ikeda T
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1149-52. PubMed ID: 10752953
[TBL] [Abstract][Full Text] [Related]
15. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin.
Wiessner C; Allegrini PR; Ekatodramis D; Jewell UR; Stallmach T; Gassmann M
J Cereb Blood Flow Metab; 2001 Jul; 21(7):857-64. PubMed ID: 11435798
[TBL] [Abstract][Full Text] [Related]
16. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition.
Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M
J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695
[TBL] [Abstract][Full Text] [Related]
17. Role of nitric oxide in hemorrhagic shock-induced bacterial translocation.
Hua TC; Moochhala SM
J Surg Res; 2000 Oct; 93(2):247-56. PubMed ID: 11027467
[TBL] [Abstract][Full Text] [Related]
18. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
Kaikita K; Schoenhard JA; Painter CA; Ripley RT; Brown NJ; Fogo AB; Vaughan DE
J Mol Cell Cardiol; 2002 Jun; 34(6):617-27. PubMed ID: 12054849
[TBL] [Abstract][Full Text] [Related]
19. Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin.
Wagner KF; Katschinski DM; Hasegawa J; Schumacher D; Meller B; Gembruch U; Schramm U; Jelkmann W; Gassmann M; Fandrey J
Blood; 2001 Jan; 97(2):536-42. PubMed ID: 11154234
[TBL] [Abstract][Full Text] [Related]
20. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis.
Shibata J; Hasegawa J; Siemens HJ; Wolber E; Dibbelt L; Li D; Katschinski DM; Fandrey J; Jelkmann W; Gassmann M; Wenger RH; Wagner KF
Blood; 2003 Jun; 101(11):4416-22. PubMed ID: 12576335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
